Europa Biosite Joins Forces with EQT for Expansion in Life Sciences

EQT Healthcare Growth has announced its acquisition of a majority stake in Europa Biosite, a principal distributor of life science reagents used predominantly by academic and biopharma researchers across Europe and North America. This strategic acquisition from Adelis Equity is part of EQT’s plan to bolster its position in the specialized distribution sector, leveraging its longstanding expertise. Europa Biosite is poised to take advantage of EQT's vast network and experience in scaling healthcare companies and distribution. Plans for the newly acquired company include bolstering its commercial stance through digital improvements, product expansion, and a proactive M&A strategy. The planned growth strategy is supported by the historical performance and expertise of EQT in related sectors and previous involvements in similar companies like Azelis and Beijer Ref. Senior EQT advisor Kate Swann is set to play a pivotal role in this evolution, assuming the role of chairperson to drive forward the company's scaling potential in the life sciences industry.